Please login to the form below

F-Star

This page shows the latest F-Star news and features for those working in and with pharma, biotech and healthcare.

Cancer disruptor F Star names next CEO

Dr Eliot Forster takes reins from Dr John Haurum. UK-based biotech F-star has named Dr Eliot Forster as its new chief executive. ... I believe that F-star’s first-in-class molecules bring together in a single form, the full power of IO and combinations.

Latest news

BMS taps F-star Alpha for immuno-oncology drug

Drug in development for breast and stomach cancers. Bristol-Myers Squibb (BMS) has hatched a plan to buy Austrian biotech F-star Alpha in order to claim rights to FS102, a ... F-star has its headquarters in Vienna but runs its research operations out of
f-star wins €15m investment

Antibody specialist f-star secures funding from existing investors and adds new members to its supervisory board. ... f-star, a company developing antibody-based products, has secured 15m of new financing.
Survival strategy

During November and December 2010 there were five Big Pharma discovery deals involving Boehringer Ingelheim (with f-star), S-A (with Avila Therapeutics), Pfizer (with Phylogica), Tanabe Research Laboratories (with Anaphore) ... f-star/Boehringer
PM Society Awards 2005

These days you're lucky if you can give them a three-star hotel and a f ing biro. ... He also issued a thinly-veiled warning to any entrants who had been honoured with a highly commended': Congratulations and all that but stay in your f ing seat.

More from news
Approximately 2 fully matching, plus 3 partially matching documents found.

Latest Intelligence

Deal Watch table for October 2014

525. F-star Alpha/BMS. Option to acquire F-star Alpha. Includes FS102 a P1 ready treatment for HER2 positive patients with breast / gastric cancer.
Pharma deals during October 2014

A major feature throughout 2014 has been the deployment of options. This month is no exception with Bristol-Myers Squibb (BMS) securing an exclusive option to acquire F-star Alpha gaining

More from intelligence
Approximately 0 fully matching, plus 2 partially matching documents found.

Latest appointments

Immunocore names new CEO, Nanoform adds to commercial team and Verona hires CMO

Jallal will succeed Andrew Hotchkiss, who has served as interim CEO after Eliot Forster (pictured above) left the company to head up cancer disrupter F Star last year.
ImmuneXcite boosts senior leadership

Edwards is currently executive chairman at F-star, having previously served as its chief executive officer, and brings over 30 years of biotechnology expertise from Adnexus Therapeutics, Genetics Institute/Wyeth and
F-star appoints vice president of protein sciences

Mike Davies joins from CPI Biologics. Vienna-headquartered biopharmaceutical company F-star has appointed Mike Davies as vice president of protein sciences at its Cambridge, UK research site. ... John Haurum, chief executive officer of F-star, said:
F-star appoints GSK's Neil Brewis

Cambridge-based antibody research company F-Star has appointed Dr Neil Brewis as chief scientific officer. . ... John Haurum CEO of F-Star, said: “We are very pleased to welcome Neil to our team.
ReNeuron makes shifts and additions to senior team

Grimster has extensive experience in advanced biologics development as has served in senior developments roles at businesses including F-star, Antisoma and Celltech.

More from appointments
Approximately 2 fully matching, plus 3 partially matching documents found.

Featured jobs

Senior Account Manager- Pharma and Life Scienes: Competitive salary and benefits

Science Writer, Healthcare Advertising Agency: £40, 000 - 45, 000 DOE benefits,

Editorial/ Medical Director – Med Ed & Comms – Home-based...: Salary TBC

Account Manager, Medical Communications and Marketing: £30, 000 – £40, 000 benefits and bonus

Account Manager, MedicalCommunications/ Healthcare PR: benefits

Editorial / Copy Lead – Healthcare Advertising – Central London...: Salary TBC

Senior / Principal Medical Writer - MedComms - Home Based / Vari...: Excellent Remuneration Packages

Home-based Principal Medical Writer – Medical Comms: Salary TBC

Freelance Medical Writer - Healthcare Advertising - London: Employment Type:. Type of Job:. Region:. Salary:. 250 to 330 per day

Senior Account Director/ Associate Director- Pharma and Life Sci...: Competitive salary and benefits

Senior Medical Writer: Salary TBC

Senior Medical Writer: Competitive salary and benefits

PR Associate Director – Consumer Health & Beauty: Salary TBC

Account Director, Medical Education: Salary TBC

Account Manager / Senior Account Manager - Healthcare Advertisin...: Excellent Remuneration

Account Director – London based Medical Communications Agency: Excellent Remuneration Package

Project Manager - Digital Healthcare - London: Excellent Remuneration Package

Experienced / Senior Account Director - Publications - London: Up to £80, 000 plus great benefits

Project Manager - Medical Communications – South Wales: Excellent Remuneration Package

Editor – Medical Education Agency – Bucks: Salary TBC

Director – Healthcare PR: Salary TBC

Hybrid Role - Principal Medical Writer / Account Handler - Publi...: Salary TBC

Subscribe to our email news alerts

PMHub

Add my company

Merrill Brink International

Merrill Brink International is a leading provider of life sciences, legal, financial, manufacturing and corporate language solutions for global companies....

Latest intelligence

From lay summaries to patient engagement programmes: how patient-centricity is finally becoming a reality: How pharma is progressing their commitment in patient engagement...
Cuttsy+Cuttsy awarded CPD Platinum by the IPA: Four years after being awarded Gold for their continuous professional development (CPD) Cuttsy+Cuttsy (C+C) have reached another milestone and been awarded Platinum accreditation....
Breaking Bad: Six behaviours separate the good brand teams from the bad...